[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-404141-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-404141-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","school-nursing-evidence-based-clinical-practice-guideline-students-with-type-i-diabetes","School Nursing Evidence-Based Clinical Practice Guideline - Students with Type I Diabetes","","School Nursing Evidence-Based Clinical Practice Guideline: Students with Type I Diabetes outlines clinical rationale and foundational background for supporting students from prekindergarten through 12th grade with type 1 diabetes. It explains diabetes categories, emphasizes that the guideline focuses specifically on type 1 due to distinct pathophysiology, and describes autoimmune beta-cell destruction leading to insulin deficiency. The guideline notes that individuals require timely exogenous insulin and discusses diabetes-related risk from elevated blood glucose and contributing environmental and genetic factors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/school-nursing-evidence-based-clinical-practice-guideline-students-with-type-i-diabetes/404141/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/school-nursing-evidence-based-clinical-practice-guideline-students-with-type-i-diabetes/404141.png","ImageObject",300,407,{"name":42,"@type":43},"Cipher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-27",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does the guideline focus only on students with Type 1 Diabetes?","Question",{"text":63,"@type":64},"It focuses on type 1 diabetes because, while there is some overlap in care and treatment modalities, the pathophysiology differs across diabetes types. Therefore, the Clinical Practice Guideline (CPG) targets students with T1D.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the underlying problem in type 1 diabetes described in the guideline?",{"text":68,"@type":64},"The immune system attacks pancreatic beta cells where insulin is produced, usually resulting in complete insulin deficiency. This leads individuals with T1D to require exogenous insulin.",{"name":70,"@type":61,"acceptedAnswer":71},"How is diabetes risk related to elevated blood glucose in the guideline?",{"text":72,"@type":64},"The guideline states that diabetes results in increased blood glucose levels, which creates risk for microvascular and macrovascular complications.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},404141,1791095945,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","School Nursing Evidence-Based  \nClinical Practice Guideline: Students with Type I Diabetes  \n[nasn.org](nasn.org)  \nSchool Nursing Evidence-Based Clinical Practice Guideline: Students with  \nType I Diabetes  \nAuthors  \nLori Wilt, PhD, RN, NJ-CSN, CNE  \nAssistant Professor Seton Hall University Nutley, NJ  \nBeth Jameson, PhD, RN, NJ-CSN  \nAssistant Professor Seton Hall University Nutley, NJ  \nNASN Lead  \nErin D. Maughan, PhD, RN, PHNA-BC, FNASN, FAAN  \nDirector of Research Silver Spring, MD  \nNASN would like to thank the following reviewers for their valuable contributions to the Clinical Practice Guideline:  \nAnna Barash, BSN, RN, CDCES  \nResearch Nurse, Benaroya Research Institute Seattle, WA  \nNakia Best, PhD, RN  \nAssistant Professor, University of California, Irvine Irvine, CA  \nRosemary Briars, ND, PNP-BC, CDCES  \nJDRF  \nClinical Program Director, La Ribida Children’s Hospital Chicago, IL  \nMarilyn Clougherty, MSN, RN, CDCES  \nSafe at School Working Group, American Diabetes Association Tandem Diabetes Care*  \nDunblane, CT  \nCarla E. Cox, PhD  \nAssociation of Diabetes Care & Education Specialists Kamas, UT  \nCheryl De Pinto, MD, MPH, FAAP  \nCouncil of School Health, American Academy of Pediatrics Baltimore, MD  \n2 | School Nursing Evidence-Based Clinical Practice Guideline: Students with Type I Diabetes © 2021  \nEmily Frank, MD  \nCouncil of School Health, American Academy of Pediatrics Oakland CA  \nTara Kaup, MSN, RN, NCSN, CDCES  \nLicensed School Nurse, Saint Paul Public Schools St Paul, MN  \nTerri Lipman, PhD, CRNP, FAAN  \nAssistant Dean for Community Engagement Miriam Stirl Endowed Term Professor of Nutrition  \nProfessor of Nursing of Children University of Pennsylvania Philadelphia, PA  \nEllen McCabe, PhD, PNP-BC, RN  \nAssistant Professor, The City University of New York New York, NY  \nCynthia E. Muñoz, PhD, MPH  \nSafe at School Working Group, American Diabetes Association Los Angeles, CA  \nMargaret Pellizzari, MBA, MS, RN, CDCES, CDTC, FADCES  \nAssociation of Diabetes Care & Education Specialists New Hyde Park, NY  \nJanet Rodriguez, BSN, RN, CDCES, CRA-USF/Advanced  \nCouncil of School Health, American Academy of Pediatrics Tampa, FL  \nCarol Schaumleffel, DNP, RN, LSN  \nAssistant Professor, Ohio University Athens, OH  \nLeslie N. Timperman, BSN, RN  \nSchool Nurse, Rochambeau The French International School Bethesda, MD  \nDianneWeisner, MSN, APRN, CNP, CNS, CDCES, CPN  \nProgram Education Coordinator Diabetes, Akron Children’s Hospital Mahoning Valley Boardman, OH  \nCrystal Woodward, MPS  \nStaff Lead, Safe at School Working Group, American Diabetes Association Arlington, VA  \nLeah Wyckoff, MS, BSN, RN, NCSN  \nPediatric Diabetes Nurse Educator, Barbara Davis Center for Childhood Diabetes Parker, CO  \n*Reviewer disclosed stock in diabetes technology. She reviewed the document in her role as a member of ADA’s Safe at School Working Group.  \n3 | School Nursing Evidence-Based Clinical Practice Guideline: Students with Type I Diabetes © 2021  \nNASN would like to thank the following clinical guideline expert reviewers for their valuable contributions to the Clinical Practice Guideline:  \nMartha Engelke, PhD, RN, CNE, FAAN  \nEmeritus Professor, East Carolina University Greenville, NC  \nRobinA. Shannon, DNP, RN, NCSN, PHNA-BC  \nClinical Assistant Professor, University of Illinois Chicago Chicago, IL  \nSusan K. Malone, PhD, RN  \nAssistant Professor, New York University, Rory Meyers College of Nursing New York City, NY  \nMayumi Willgerodt, PhD, MPH, RN  \nAssociate Professor, University of Washington Seattle, WA  \nSuggested citation: National Association of School Nurses. (2021). School nursing  \nevidence-based clinical practice guideline: Students with type I diabetes.  \nAll evidence-based clinical guidelines from the National Association of School Nurses automatically expire five years after publication unless reaffirmed, revised, or retired at or before that time.  \nCopyright 2021 by the National Association of School Nurses (NASN","cbCaibmts5gMU3CH","https://ap.wps.com/l/cbCaibmts5gMU3CH","pdf",1370580,109,"English","# Rationale\n## Diabetes categories and scope of the guideline\n## Type 1 diabetes pathophysiology and insulin needs","[{\"question\":\"Why does the guideline focus only on students with Type 1 Diabetes?\",\"answer\":\"It focuses on type 1 diabetes because, while there is some overlap in care and treatment modalities, the pathophysiology differs across diabetes types. Therefore, the Clinical Practice Guideline (CPG) targets students with T1D.\"},{\"question\":\"What is the underlying problem in type 1 diabetes described in the guideline?\",\"answer\":\"The immune system attacks pancreatic beta cells where insulin is produced, usually resulting in complete insulin deficiency. This leads individuals with T1D to require exogenous insulin.\"},{\"question\":\"How is diabetes risk related to elevated blood glucose in the guideline?\",\"answer\":\"The guideline states that diabetes results in increased blood glucose levels, which creates risk for microvascular and macrovascular complications.\"}]","School Nursing Evidence-Based Clinical Practice Guideline - Students with Type I Diabetes | PDF",1790546030,275]